Abstract

GENESIS OF DREADFUL BLACK FUNGUS INFECTION IN COVID 19 PATIENTS BY VIRTUE OF STEROIDAL THERAPY

*Hero Khan Pathan

ABSTRACT

Mucormycosis is a high-morbidity and mortal Angio-invasive fungal infection. Mucormycotic prevalence is about 1.7 out of 1 000 000 habitats a year. Mucormycosis is mostly caused by ketoacidosis (diabetic or other), Iatrogenic immunosuppression, the use of corticosteroids or deferoxamines, catheter and other catheter-contaminated mucocutaneous damage as well as bandage contact. Mucorales penetrate deep tissues by airborne breathing, inoculation or absorption of airborne spores. A high percentage of patients are colonised, but they do not inhibit them. In the sinus (39%), lungs (24%), skin (19%), brain (9%) and gastrointestinal tract (7%), disseminated diseases (6%) and elsewhere, Mucormycosis more often occur (6 percent). In COVID, 19 patients who are reliant on steroidal treatment to recover from SARS CoV-2, unregulated diabetes and/or immunosuppressants, are recognised to be life-threatening infections caused by virulent angio-invasive moulds with a growing frequency. Mucormycosis is very difficult to diagnose and treat. Progress in recognising pathogenesis and early identification will increase chances for successful management and even cure of this debilitating infection and the recent availability of active, not toxic medicines.

Keywords: Mucormycosis, CoVID 19, Anti-fungal drugs, Black fungus, COVID 19 and Mucormycosis.